AAV technology
AGTC Announces New Corporate Office and Laboratory Facility
Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, recently announced the opening of a new combined use corporate office and laboratory facility in the rapidly growing North Central Florida biotech corridor. AGTC was founded based on technology developed at...